Integral Biosciences - Integrated Drug Discovery Services

  Drug discovery consists of a wide array of methods. It takes 10-12 years on average and costs approximately USD 2 billion to launch a new viable drug in the market. Scientists at a contract research organization apply several qualitative and quantitative analyses to deliver lead drug candidates in the shortest time frame possible. DMPK (Drug Metabolism and Pharmacokinetics) is one of the most vital parts of  drug discovery services . What is DMPK (Drug Metabolism and Pharmacokinetics)? Drug metabolism and pharmacokinetics methods help to determine the promising drug candidates for further investigation and development processes. DMPK studies are performed by  contract research organizations in India  throughout the drug development processes to determine the pharmacological characteristics of a compound such as absorption, distribution, metabolism, excretion (ADME), and pharmacokinetic characteristics. Drug Metabolism:  The metabolism process is the breaking of an administered drug m

The Computational drug discovery services or CADD capabilities is vital for almost all the stages of preclinical development solutions . It is utilised by drug discovery CROs for numerous purposes in drug designing such as Target identification Service, HIT discovery Service, Lead Optimization Service and so on.   Computational Drug Design Empowers CROs Whether it is high throughput screening, molecular modelling, analogue designing, structural biology computational capabilities empowers drug discovery laboratories a lot. Experts there can identify the binding affinity of the potential drug compound with the appropriate target. A well-established drug discovery CRO has to utilize computational chemistry, structural biology, molecular modelling and simulation to aid in computational drug design & discovery services. CADD also helps CROs to deliver meticulous ligand-based drug-based as well as structure-based drug discovery services. Major Applications of CADD in Drug Disc